| Title : Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans - Ahren_2011_Diabetes.Obes.Metab_13_775 |
| Author(s) : Ahren B , Schweizer A , Dejager S , Villhauer EB , Dunning BE , Foley JE |
| Ref : Diabetes Obes Metab , 13 :775 , 2011 |
| Abstract : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| ESTHER : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| PubMedSearch : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| PubMedID: 21507182 |
| Title : Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes - D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| Author(s) : D'Alessio DA , Denney AM , Hermiller LM , Prigeon RL , Martin JM , Tharp WG , Saylan ML , He Y , Dunning BE , Foley JE , Pratley RE |
| Ref : J Clinical Endocrinology Metab , 94 :81 , 2009 |
| Abstract : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| ESTHER : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| PubMedSearch : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| PubMedID: 18957505 |
| Title : Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes - Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| Author(s) : Ahren B , Schweizer A , Dejager S , Dunning BE , Nilsson PM , Persson M , Foley JE |
| Ref : J Clinical Endocrinology Metab , 94 :1236 , 2009 |
| Abstract : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| ESTHER : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| PubMedSearch : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| PubMedID: 19174497 |
| Title : The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients - Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| Author(s) : Balas B , Baig MR , Watson C , Dunning BE , Ligueros-Saylan M , Wang Y , He YL , Darland C , Holst JJ , Deacon CF , Cusi K , Mari A , Foley JE , DeFronzo RA |
| Ref : J Clinical Endocrinology Metab , 92 :1249 , 2007 |
| Abstract : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| ESTHER : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| PubMedSearch : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| PubMedID: 17244786 |
| Title : Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes - Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| Author(s) : Mari A , Sallas WM , He YL , Watson C , Ligueros-Saylan M , Dunning BE , Deacon CF , Holst JJ , Foley JE |
| Ref : J Clinical Endocrinology Metab , 90 :4888 , 2005 |
| Abstract : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| ESTHER : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| PubMedSearch : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| PubMedID: 15886245 |
| Title : 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties - Villhauer_2003_J.Med.Chem_46_2774 |
| Author(s) : Villhauer EB , Brinkman JA , Naderi GB , Burkey BF , Dunning BE , Prasad K , Mangold BL , Russell ME , Hughes TE |
| Ref : Journal of Medicinal Chemistry , 46 :2774 , 2003 |
| Abstract : Villhauer_2003_J.Med.Chem_46_2774 |
| ESTHER : Villhauer_2003_J.Med.Chem_46_2774 |
| PubMedSearch : Villhauer_2003_J.Med.Chem_46_2774 |
| PubMedID: 12801240 |
| Title : 1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties - Villhauer_2002_J.Med.Chem_45_2362 |
| Author(s) : Villhauer EB , Brinkman JA , Naderi GB , Dunning BE , Mangold BL , Mone MD , Russell ME , Weldon SC , Hughes TE |
| Ref : Journal of Medicinal Chemistry , 45 :2362 , 2002 |
| Abstract : Villhauer_2002_J.Med.Chem_45_2362 |
| ESTHER : Villhauer_2002_J.Med.Chem_45_2362 |
| PubMedSearch : Villhauer_2002_J.Med.Chem_45_2362 |
| PubMedID: 12036346 |